Caplin One Labs Limited - Due diligence report

A 360° intelligence report on Caplin One Labs Limited: trust score, financial health, credit view, compliance, directors, growth and distres…

2021-06-02 Chennai, Tamil Nadu Active Unlisted Active Compliant
Share
CO Caplin One Labs Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Caplin One Labs Limited — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Caplin One Labs Limited is assessed as Low Risk with a Trust Score of 77/100. Caplin One Labs Limited is an active public limited indian non-government company incorporated in 2021, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Caplin One Labs Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
90/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Working-capital cover adequate.

Charges position: 1 open (4.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Compliance Score: 90/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 2 auditor resignation(s) filed - latest: M RAGHUNATH AND CO on 2023-06-30.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
Sivakumar 01234567 Director 01/04/2018 6 yrs Approved
SRIDHAR GANESAN 01234567 Director 01/04/2018 6 yrs Approved
PARTHEEBAN VIVEK SIDDARTH 01234567 Director 01/04/2018 6 yrs Approved
DESIKACHARI MURALIDHARAN 01234567 Director 01/04/2018 6 yrs Approved
DAMODARAN SATHYANARAYANAN 01234567 Director 01/04/2018 6 yrs Approved
PAARTHIPAN CHINGELPUT CHELLAPPAN 01234567 Director 01/04/2018 6 yrs Approved
DEENADAYALAN SINGARAM 01234567 Director 01/04/2018 6 yrs Approved
  • 7 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Caplin Point Laboratories Limited
Subsidiaries
-
Group entities
-
Capital events
11 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Caplin Point Laboratories Limited Holding Company 74.00%

Key managerial personnel: Sivakumar (Whole-time director) · DESIKACHARI MURALIDHARAN (CFO)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +38% over 2 year(s).
Latest year revenue grew 1.42.
Asset base grew 2.1x - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 5 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 24% in a year.
1 open charge(s) registered - assets are encumbered.
2 auditor resignation(s) on record - review the stated reasons.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment61/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 4.00 cr already registered.
  • Compliance record supports lending.
Investor view76/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
19 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
25 Oct 2024
Charge created
Others - 4.00 cr
27 Sep 2024
Director ceased
DAMODARAN SATHYANARAYANAN
Director ceased
DEENADAYALAN SINGARAM
06 May 2024
Director appointed
DAMODARAN SATHYANARAYANAN (Director)
Director appointed
DEENADAYALAN SINGARAM (Director)
31 Dec 2022
Securities allotted
10000000 Equity Shares - 10.00 cr raised
11 Nov 2022
Director appointed
Sivakumar (Whole-time director)
30 Sep 2022
Securities allotted
5300000 Equity Shares - 5.30 cr raised
03 Jul 2022
Securities allotted
1500000 Equity Shares - 1.50 cr raised
28 May 2022
Securities allotted
3200000 Equity Shares - 3.20 cr raised
28 Apr 2022
Securities allotted
2742000 Equity Shares - 2.74 cr raised
25 Mar 2022
Securities allotted
8962500 Equity Shares - 8.96 cr raised
21 Feb 2022
Securities allotted
10500000 Equity Shares - 10.50 cr raised
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 2 financial year(s).
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
7 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Capital has been raised through 11 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Vecnost Biotechnology Private Limited U24290PB2021PTC053235 Amritsar, Punjab, India
Maskon Life Sciences Private Limited U33100UR2018PTC009027 Haridwar, Uttarakhand, India
Bio Trans Pharmaceuticals Private Limited U24231TN1989PTC018382 Athipattu, Tamil Nadu, India
Eurofrits India Private Limited U26999GJ2021PTC125150 Ahmedabad, Gujarat, India
Seamac Formulations Private Limited U24232PB2007PTC030836 Talwara, Punjab, India
Pharmawind Healthcare Private Limited U24239GJ2019PTC106440 Surat, Gujarat, India
Captavis Biocare Private Limited U24290GJ2021PTC121485 Bavla, Gujarat, India
Invision Pharma Limited U24304KA2018PLC113264 Bengaluru, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Caplin One Labs Limited before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Caplin One Labs Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Caplin One Labs Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Caplin One Labs Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Caplin One Labs Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Caplin One Labs Limited an active company?

Caplin One Labs Limited has MCA status “Active” with a compliance score of 90/100 (Low Risk).

Is Caplin One Labs Limited financially healthy?

Caplin One Labs Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Caplin One Labs Limited?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Caplin One Labs Limited?

The ultimate holding entity is Caplin Point Laboratories Limited. 7 active director(s) are on record.

Does Caplin One Labs Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Caplin One Labs Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 90/100 (Low Risk).

Is it risky to lend to Caplin One Labs Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.